Filter by Topic
Find events that are specific to your needs.
2 Events Found
Thursday, October 29, 2020
Immunotherapies have radically changed treatment for non-small cell lung cancer (NSCLC) patients. In fact, the PD-L1/PD-1 blockade is a bona fide breakthrough. What does this fast-moving course of research and treatment mean for lung cancer patients of all persuasions?
Thursday, November 19, 2020
The majority of lung cancer patients have non-small cell lung cancer (NSCLC), and a small percentage of those patients have the RET gene, also called RET fusion-positive lung cancer.